You are viewing the site in preview mode
Skip to main content
|
Indicator
|
Total
|
n
|
% (95% CI)
|
|---|
|
Two-week morbidity prevalence (N = 1482)
|
|
Any illness
|
1479*
|
637
|
43.1% (40.6–45.6)
|
|
Gynaecological illness
|
334a
|
19
|
5.7% (3.6–8.8)
|
|
Non-communicable disease prevalence among adults (N = 582)
|
|
Any NCD
|
582
|
165
|
28.4% (24.8–32.3)
|
|
CVD
|
582
|
29
|
5.0% (3.5–7.1)
|
|
Hypertension
|
582
|
28
|
4.8% (3.3–6.9)
|
|
Disability
|
582
|
25
|
4.3% (2.9–6.3)
|
|
Asthma and other chronic respiratory conditions
|
582
|
24
|
4.1% (2.8–6.1)
|
|
Musculoskeletal disease (incl. arthritis)
|
582
|
23
|
4.0% (2.6–5.9)
|
|
Diabetes
|
582
|
22
|
3.8% (2.5–5.7)
|
|
Vaccination coverage in children aged 6–59 months (N = 263)
|
|
One dose of BCG
|
259*
|
222
|
85.7% (80.9–89.5)
|
|
Four doses of polio vaccine in children aged 24–59 months
|
172b
|
45
|
26.2% (20.1–33.3)
|
|
Two doses of measles vaccine aged 24–59 months
|
170b
|
47
|
27.6% (21.4–34.9)
|
|
Four doses of pentavalent vaccine aged 24–59 months
|
172b
|
35
|
20.3% (14.9–27.1)
|
|
Full immunization for BCG, polio, measles and pentavalent aged 24–59 months
|
170b
|
24
|
14.1% (9.6–20.3).
|
|
Malnutrition prevalence among children aged 6–59 months (N = 263)
|
|
GAM
|
249*
|
9
|
3.6% (1.9–6.8)
|
|
SAM
|
249*
|
0
|
–
|
- * Missing values were excluded
- a Total number of women of childbearing age (15–45 years)
- b Total number of children aged 24–59 months (N = 173), missing values excluded